Trials / Completed
CompletedNCT06316206
The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
The Use of Ethinylestradiol/Dienogest in Random Start Rapid Preparation of Endometrium Before Office Hysteroscopic Polypectomies: a Multicenter, Prospective, Randomized Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University of Palermo · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of Ethinylestradiol/Dienogest, in rapid preparation of endometrium for hysteroscopic polypectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethinylestradiol/Dienogest 0.03mg/2mg | Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-08-01
- Completion
- 2024-03-01
- First posted
- 2024-03-18
- Last updated
- 2024-04-22
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06316206. Inclusion in this directory is not an endorsement.